Polgar Orsolya, Robey Robert W, Morisaki Kuniaki, Dean Michael, Michejda Christopher, Sauna Zuben E, Ambudkar Suresh V, Tarasova Nadya, Bates Susan E
Cancer Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20892, USA.
Biochemistry. 2004 Jul 27;43(29):9448-56. doi: 10.1021/bi0497953.
ABCG2 (BCRP/MXR/ABCP) is a half-transporter associated with multidrug resistance that presumably homodimerizes for function. It has a conserved GXXXG motif in its first transmembrane segment, a motif that has been linked with dimerization in other proteins, e.g., glycophorin A. We substituted either or both glycines of this GXXXG motif with leucines to evaluate the impact on drug transport, ATP hydrolysis, cross-linking, and susceptibility to degradation. All mutants also carried the R482G gain-of-function mutation, and all migrated to the cell surface. The mutations resulted in lost transport for rhodamine 123 and impaired mitoxantrone, pheophorbide a, and BODIPY-prazosin transport, particularly in the double leucine mutant (G406L/G410L). Basal ATPase activity of the G406L/G410L mutant was comparable to the empty vector transfected cells with no substrate induction. Despite impaired function, the mutants retained susceptibility to cross-linking using either disuccinimidyl suberate (DSS) or the reducible dithiobis(succinimidyl propionate) (DSP) and demonstrated a high molecular weight complex under nonreducing conditions. Mutations to alanine at the same positions yielded fully functional transporters. Finally, we exposed cells to mitoxantrone to promote folding and processing of the mutant proteins, which in the leucine mutants resulted in increased amounts detected on immunoblot and by immunofluorescence. These studies support a hypothesis that the GXXXG motif promotes proper packing of the transmembrane segments in the functional ABCG2 homodimer, although it does not solely arbitrate dimerization.
ABCG2(BCRP/MXR/ABCP)是一种与多药耐药相关的半转运蛋白,可能通过同源二聚化发挥功能。它在其第一个跨膜区段具有保守的GXXXG基序,该基序在其他蛋白质(如血型糖蛋白A)中与二聚化有关。我们将此GXXXG基序中的一个或两个甘氨酸替换为亮氨酸,以评估对药物转运、ATP水解、交联和降解敏感性的影响。所有突变体还携带R482G功能获得性突变,并且都迁移到细胞表面。这些突变导致罗丹明123转运丧失,米托蒽醌、脱镁叶绿酸a和BODIPY-哌唑嗪转运受损,尤其是在双亮氨酸突变体(G406L/G410L)中。G406L/G410L突变体的基础ATP酶活性与未转染底物诱导的空载体细胞相当。尽管功能受损,但这些突变体对使用辛二酸二琥珀酰亚胺酯(DSS)或可还原的二硫代双(琥珀酰亚胺丙酸酯)(DSP)进行交联仍敏感,并且在非还原条件下显示出高分子量复合物。在相同位置突变为丙氨酸产生了功能完全正常的转运蛋白。最后,我们将细胞暴露于米托蒽醌以促进突变蛋白的折叠和加工,这在亮氨酸突变体中导致免疫印迹和免疫荧光检测到的量增加。这些研究支持了一个假设,即GXXXG基序促进功能性ABCG2同源二聚体中跨膜区段的正确组装,尽管它并非唯一决定二聚化。